Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Testing | 23 | 2023 | 3439 | 1.770 |
Why?
|
Genetic Variation | 25 | 2023 | 6540 | 1.140 |
Why?
|
Sequence Analysis, DNA | 14 | 2020 | 4801 | 1.080 |
Why?
|
Genome, Human | 18 | 2023 | 4420 | 0.990 |
Why?
|
Genomics | 23 | 2023 | 5692 | 0.910 |
Why?
|
Computational Biology | 10 | 2022 | 3518 | 0.760 |
Why?
|
Pathology, Molecular | 4 | 2022 | 325 | 0.740 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 3585 | 0.720 |
Why?
|
Noonan Syndrome | 2 | 2017 | 120 | 0.680 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2017 | 234 | 0.610 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2017 | 20 | 0.590 |
Why?
|
Databases, Genetic | 10 | 2021 | 1780 | 0.530 |
Why?
|
Software | 8 | 2020 | 4434 | 0.530 |
Why?
|
Information Dissemination | 5 | 2021 | 1100 | 0.520 |
Why?
|
Genetic Predisposition to Disease | 23 | 2023 | 17400 | 0.520 |
Why?
|
Prion Diseases | 1 | 2016 | 88 | 0.500 |
Why?
|
Blood Group Antigens | 3 | 2022 | 179 | 0.500 |
Why?
|
GTP Phosphohydrolases | 2 | 2017 | 508 | 0.480 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2022 | 1263 | 0.480 |
Why?
|
Prions | 1 | 2016 | 181 | 0.480 |
Why?
|
Hyperlipoproteinemia Type II | 3 | 2024 | 373 | 0.450 |
Why?
|
Germ-Line Mutation | 3 | 2017 | 1786 | 0.430 |
Why?
|
Genetic Diseases, Inborn | 4 | 2020 | 587 | 0.430 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1780 | 0.420 |
Why?
|
Penetrance | 3 | 2023 | 380 | 0.370 |
Why?
|
Metamorphosis, Biological | 2 | 2009 | 37 | 0.360 |
Why?
|
DNA Copy Number Variations | 2 | 2015 | 1940 | 0.350 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12220 | 0.340 |
Why?
|
Disease | 3 | 2021 | 681 | 0.340 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2020 | 65 | 0.340 |
Why?
|
Sexual Development | 1 | 2009 | 34 | 0.340 |
Why?
|
Antigens, Human Platelet | 2 | 2019 | 43 | 0.330 |
Why?
|
Blood Grouping and Crossmatching | 2 | 2019 | 106 | 0.320 |
Why?
|
Genetic Counseling | 3 | 2023 | 600 | 0.320 |
Why?
|
Algorithms | 7 | 2019 | 13853 | 0.320 |
Why?
|
Mutation, Missense | 3 | 2019 | 2556 | 0.320 |
Why?
|
Biological Specimen Banks | 4 | 2021 | 707 | 0.310 |
Why?
|
Laboratories | 3 | 2023 | 461 | 0.300 |
Why?
|
Hypercholesterolemia | 2 | 2024 | 1149 | 0.280 |
Why?
|
Workflow | 3 | 2022 | 846 | 0.280 |
Why?
|
Drosophila melanogaster | 3 | 2010 | 1704 | 0.270 |
Why?
|
Cardiomyopathies | 4 | 2020 | 1912 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11695 | 0.240 |
Why?
|
Genes, BRCA2 | 2 | 2017 | 617 | 0.240 |
Why?
|
Multifactorial Inheritance | 3 | 2020 | 1190 | 0.240 |
Why?
|
BRCA2 Protein | 2 | 2019 | 790 | 0.230 |
Why?
|
Genes, BRCA1 | 2 | 2017 | 780 | 0.230 |
Why?
|
Vinculin | 2 | 2020 | 62 | 0.220 |
Why?
|
Neonatal Screening | 3 | 2023 | 591 | 0.210 |
Why?
|
Quality Improvement | 1 | 2017 | 3738 | 0.210 |
Why?
|
Alleles | 4 | 2023 | 6931 | 0.210 |
Why?
|
BRCA1 Protein | 2 | 2019 | 1145 | 0.210 |
Why?
|
Pharmacogenetics | 3 | 2022 | 676 | 0.210 |
Why?
|
Humans | 75 | 2024 | 742088 | 0.200 |
Why?
|
Risk Assessment | 4 | 2023 | 23320 | 0.200 |
Why?
|
MNSs Blood-Group System | 1 | 2020 | 8 | 0.190 |
Why?
|
Heart Diseases | 1 | 2014 | 2789 | 0.190 |
Why?
|
Membrane Proteins | 2 | 2017 | 7873 | 0.190 |
Why?
|
Genetics, Medical | 1 | 2023 | 337 | 0.180 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2020 | 851 | 0.180 |
Why?
|
Sexual Behavior, Animal | 2 | 2010 | 113 | 0.170 |
Why?
|
Genes, Insect | 2 | 2010 | 268 | 0.170 |
Why?
|
Biotinidase | 1 | 2018 | 19 | 0.170 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2019 | 768 | 0.160 |
Why?
|
RNA, Messenger | 1 | 2013 | 13029 | 0.160 |
Why?
|
Canada | 3 | 2021 | 2061 | 0.160 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2016 | 3920 | 0.160 |
Why?
|
Electronic Health Records | 5 | 2018 | 4440 | 0.150 |
Why?
|
Research Design | 3 | 2020 | 5979 | 0.150 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9410 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2018 | 264 | 0.140 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 379 | 0.130 |
Why?
|
Primary Health Care | 3 | 2023 | 4551 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 2018 | 367 | 0.130 |
Why?
|
Health | 1 | 2019 | 390 | 0.130 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 161 | 0.130 |
Why?
|
Government Programs | 1 | 2017 | 275 | 0.130 |
Why?
|
Guidelines as Topic | 2 | 2018 | 1402 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2431 | 0.120 |
Why?
|
ras Proteins | 1 | 2019 | 1060 | 0.120 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2014 | 60 | 0.120 |
Why?
|
Infant, Newborn | 9 | 2023 | 25575 | 0.120 |
Why?
|
Skin Diseases, Genetic | 1 | 2014 | 40 | 0.110 |
Why?
|
Mutation | 5 | 2021 | 29717 | 0.110 |
Why?
|
Medical History Taking | 1 | 2017 | 783 | 0.110 |
Why?
|
Science | 1 | 2016 | 241 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2019 | 15494 | 0.110 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2014 | 89 | 0.110 |
Why?
|
Erythrocytes | 2 | 2019 | 2452 | 0.110 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.110 |
Why?
|
Male | 30 | 2024 | 349538 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2021 | 878 | 0.110 |
Why?
|
Arthrogryposis | 1 | 2013 | 72 | 0.110 |
Why?
|
Gene Deletion | 1 | 2020 | 2751 | 0.100 |
Why?
|
Genotype | 6 | 2023 | 12946 | 0.100 |
Why?
|
Marfan Syndrome | 1 | 2014 | 240 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2714 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1811 | 0.100 |
Why?
|
Female | 31 | 2024 | 379592 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.100 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 496 | 0.100 |
Why?
|
Peer Review, Research | 1 | 2014 | 329 | 0.100 |
Why?
|
Rare Diseases | 1 | 2016 | 554 | 0.100 |
Why?
|
Chromosome Mapping | 4 | 2021 | 4742 | 0.090 |
Why?
|
Risk Factors | 9 | 2024 | 72145 | 0.090 |
Why?
|
Pupa | 1 | 2009 | 37 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4328 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2117 | 0.090 |
Why?
|
Base Sequence | 3 | 2017 | 12797 | 0.090 |
Why?
|
Databases, Factual | 2 | 2021 | 7716 | 0.080 |
Why?
|
Receptors, Steroid | 1 | 2009 | 155 | 0.080 |
Why?
|
Arteries | 1 | 2014 | 1118 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.080 |
Why?
|
Genetic Association Studies | 4 | 2020 | 2699 | 0.080 |
Why?
|
Vascular Malformations | 1 | 2014 | 450 | 0.080 |
Why?
|
Coronary Disease | 1 | 2023 | 6078 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4664 | 0.080 |
Why?
|
Ion Channels | 1 | 2013 | 1056 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 1 | 2016 | 1694 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2024 | 3428 | 0.080 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 541 | 0.080 |
Why?
|
Pedigree | 3 | 2020 | 4646 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15108 | 0.070 |
Why?
|
Larva | 1 | 2009 | 517 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2014 | 685 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2589 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3070 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6454 | 0.070 |
Why?
|
Middle Aged | 17 | 2024 | 213127 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 742 | 0.070 |
Why?
|
Joint Instability | 1 | 2014 | 792 | 0.070 |
Why?
|
RNA Splicing | 2 | 2022 | 907 | 0.070 |
Why?
|
Adult | 16 | 2023 | 213712 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19862 | 0.060 |
Why?
|
Phenotype | 5 | 2022 | 16331 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2013 | 1162 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2267 | 0.060 |
Why?
|
Gene Frequency | 2 | 2023 | 3587 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3301 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5019 | 0.060 |
Why?
|
Health Surveys | 1 | 2013 | 4030 | 0.060 |
Why?
|
Prospective Studies | 3 | 2022 | 53187 | 0.060 |
Why?
|
Heterozygote | 2 | 2020 | 2790 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 9941 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8626 | 0.050 |
Why?
|
Duty to Recontact | 1 | 2021 | 20 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2009 | 2713 | 0.050 |
Why?
|
Cohort Studies | 5 | 2024 | 40450 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2009 | 3617 | 0.050 |
Why?
|
Genetic Research | 1 | 2021 | 174 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11039 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3306 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18112 | 0.050 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 4566 | 0.050 |
Why?
|
Drosophila Proteins | 1 | 2009 | 1699 | 0.040 |
Why?
|
North America | 1 | 2023 | 1249 | 0.040 |
Why?
|
Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
Aged | 10 | 2021 | 162944 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57683 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2585 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10856 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 440 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
Pregnancy | 2 | 2017 | 29087 | 0.040 |
Why?
|
DNA | 2 | 2022 | 7289 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 21719 | 0.040 |
Why?
|
Galactosyltransferases | 1 | 2018 | 263 | 0.040 |
Why?
|
Pennsylvania | 1 | 2018 | 613 | 0.040 |
Why?
|
Young Adult | 5 | 2024 | 56350 | 0.040 |
Why?
|
Obesity | 1 | 2019 | 12705 | 0.040 |
Why?
|
Neoplasms | 2 | 2017 | 21596 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2018 | 457 | 0.040 |
Why?
|
Gene Duplication | 1 | 2017 | 330 | 0.030 |
Why?
|
SOS1 Protein | 1 | 2016 | 41 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4465 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.030 |
Why?
|
Infant | 4 | 2021 | 35070 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5851 | 0.030 |
Why?
|
Disclosure | 1 | 2021 | 736 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2016 | 203 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 939 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 991 | 0.030 |
Why?
|
United States | 5 | 2023 | 69693 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 20774 | 0.030 |
Why?
|
Counseling | 1 | 2023 | 1521 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1328 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2354 | 0.030 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 337 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 552 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2303 | 0.030 |
Why?
|
Desmoplakins | 1 | 2014 | 62 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 85649 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1777 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 264 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 102 | 0.030 |
Why?
|
Child | 5 | 2021 | 77478 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29010 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2013 | 256 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2017 | 5019 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12071 | 0.030 |
Why?
|
Hypolipidemic Agents | 1 | 2016 | 604 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2781 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3266 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 500 | 0.030 |
Why?
|
Drug Design | 1 | 2016 | 1078 | 0.020 |
Why?
|
Incidental Findings | 1 | 2016 | 688 | 0.020 |
Why?
|
Time Factors | 2 | 2010 | 40054 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 780 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12164 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1820 | 0.020 |
Why?
|
Hearing Loss | 1 | 2016 | 765 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1679 | 0.020 |
Why?
|
Dissection | 1 | 2010 | 294 | 0.020 |
Why?
|
Olfactory Receptor Neurons | 1 | 2009 | 92 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1683 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14720 | 0.020 |
Why?
|
Family | 1 | 2019 | 3144 | 0.020 |
Why?
|
Insect Proteins | 1 | 2009 | 258 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9846 | 0.020 |
Why?
|
Blood Platelets | 1 | 2018 | 2506 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4187 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2028 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2003 | 0.020 |
Why?
|
Lipids | 1 | 2016 | 3302 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2630 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12344 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2723 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 40955 | 0.020 |
Why?
|
Head | 1 | 2010 | 878 | 0.020 |
Why?
|
Health Personnel | 1 | 2018 | 3210 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2017 | 3527 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5238 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8297 | 0.010 |
Why?
|
Health Care Costs | 1 | 2017 | 3203 | 0.010 |
Why?
|
Brain | 1 | 2010 | 26343 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3014 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13921 | 0.010 |
Why?
|
Animals | 3 | 2010 | 168561 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12695 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15530 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6754 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15194 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 77098 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15994 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 24913 | 0.010 |
Why?
|